Article
Complement-dependent mpox virus-neutralizing antibodies in infected and vaccinated individuals
2023-04-17
Abstract excerpt
<h4>ABSTRACT</h4> Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022. The Modified Vaccinia Ankara (MVA)-based vaccine was used as prophylaxis, but its effectiveness remains poorly characterized. Here, we developed two assays for quantification of neutralizing antibodies (NAbs), using MVA-GFP or a recently isolated MPXV. We measured NAb levels in 470 sera from control, MPXV-infected or...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 54255b6a-07d3-5c1d-951f-04aec1067165
- DOI
- 10.1101/2023.04.14.23288385
